These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 23448904)

  • 1. Recognition of the phenotype of thalidomide embryopathy in countries endemic for leprosy: new cases and review of the main dysmorphological findings.
    Vianna FSL; Schüler-Faccini L; Leite JCL; de Sousa SHC; da Costa LMM; Dias MF; Morelo EF; Doriqui MJR; Maximino CM; Sanseverino MTV
    Clin Dysmorphol; 2013 Apr; 22(2):59-63. PubMed ID: 23448904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacoepidemiology and thalidomide embryopathy surveillance in Brazil.
    Sales Luiz Vianna F; de Oliveira MZ; Sanseverino MT; Morelo EF; de Lyra Rabello Neto D; Lopez-Camelo J; Camey SA; Schuler-Faccini L
    Reprod Toxicol; 2015 Jun; 53():63-7. PubMed ID: 25828060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thalidomide embryopathy cases in Brazil after 1965.
    Paumgartten FJ; Chahoud I
    Reprod Toxicol; 2006 Jul; 22(1):1-2. PubMed ID: 16427249
    [No Abstract]   [Full Text] [Related]  

  • 4. The organization, weaknesses, and challenges of the control of thalidomide in Brazil: A review.
    Jesus SM; Santana RS; Leite SN
    PLoS Negl Trop Dis; 2020 Aug; 14(8):e0008329. PubMed ID: 32760161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of thalidomide use in birth defects in Brazil.
    Sales Luiz Vianna F; Kowalski TW; Fraga LR; Sanseverino MT; Schuler-Faccini L
    Eur J Med Genet; 2017 Jan; 60(1):12-15. PubMed ID: 27638330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The return of thalidomide: can birth defects be prevented?
    Lary JM; Daniel KL; Erickson JD; Roberts HE; Moore CA
    Drug Saf; 1999 Sep; 21(3):161-9. PubMed ID: 10487395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiological surveillance of birth defects compatible with thalidomide embryopathy in Brazil.
    Vianna FS; Lopez-Camelo JS; Leite JC; Sanseverino MT; Dutra Mda G; Castilla EE; Schüler-Faccini L
    PLoS One; 2011; 6(7):e21735. PubMed ID: 21754997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thalidomide in the treatment of leprosy.
    Teo S; Resztak KE; Scheffler MA; Kook KA; Zeldis JB; Stirling DI; Thomas SD
    Microbes Infect; 2002 Sep; 4(11):1193-202. PubMed ID: 12361920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Letter: Thalidomide in erythema nodosum leprosum.
    Crawford CL
    Lancet; 1973 Nov; 2(7839):1201-2. PubMed ID: 4127565
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of erythema nodosum leprosum with thalidomide.
    Crawford CL
    Lancet; 1973 Sep; 2(7828):567-8. PubMed ID: 4125333
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparative analysis of the use and control of thalidomide in Brazil and different countries: is it possible to say there is safety?
    de Jesus SM; Santana RS; Leite SN
    Expert Opin Drug Saf; 2022 Jan; 21(1):67-81. PubMed ID: 34232089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose-dependent thalidomide induced bradycardia in young erythema nodosum leprosum patient.
    Thangaraju P; Venkatesan S; Sivashanmugam E; Showkath Ali MK
    Indian J Pharmacol; 2019; 51(1):72-74. PubMed ID: 31031470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thalidomide, a current teratogen in South America.
    Castilla EE; Ashton-Prolla P; Barreda-Mejia E; Brunoni D; Cavalcanti DP; Correa-Neto J; Delgadillo JL; Dutra MG; Felix T; Giraldo A; Juarez N; Lopez-Camelo JS; Nazer J; Orioli IM; Paz JE; Pessoto MA; Pina-Neto JM; Quadrelli R; Rittler M; Rueda S; Saltos M; Sánchez O; Schüler L
    Teratology; 1996 Dec; 54(6):273-7. PubMed ID: 9098920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thalidomide for erythema nodosum leprosum and other applications.
    Okafor MC
    Pharmacotherapy; 2003 Apr; 23(4):481-93. PubMed ID: 12680478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Thalidomide used by patients with erythema nodosum leprosum].
    Valente Mdo S; Vieira JL
    Rev Soc Bras Med Trop; 2010; 43(2):201-4. PubMed ID: 20464154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of thalidomide in leprosy.
    Crawford CL
    Adverse Drug React Toxicol Rev; 1994; 13(4):177-92. PubMed ID: 7734638
    [No Abstract]   [Full Text] [Related]  

  • 17. Thalidomide in the treatment of erythema nodosum leprosum. With a note on selected laboratory abnormalities in erythema nodosum leprosum.
    Hastings RC; Trautman JR; Enna CD; Jacobson RR
    Clin Pharmacol Ther; 1970; 11(4):481-7. PubMed ID: 4913866
    [No Abstract]   [Full Text] [Related]  

  • 18. Thalidomide embryopathy: Follow-up of cases born between 1959 and 2010.
    Kowalski TW; Sanseverino MT; Schuler-Faccini L; Vianna FS
    Birth Defects Res A Clin Mol Teratol; 2015 Sep; 103(9):794-803. PubMed ID: 26043318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thalidomide in leprosy and some dermatological conditions--a review.
    Parikh DA; Maniar JK; Ganapati R
    Indian J Lepr; 1985; 57(4):862-7. PubMed ID: 3915010
    [No Abstract]   [Full Text] [Related]  

  • 20. Thalidomide enhances defective monocyte function in lepromatous leprosy.
    Nielsen H; Bennike T
    Lancet; 1984 Jul; 2(8394):98-9. PubMed ID: 6146029
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.